2015 Fiscal Year Final Research Report
Development of novel nanomedicine for metabolic syndrome
| Project/Area Number |
24680053
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (A)
|
| Allocation Type | Partial Multi-year Fund |
|---|
| Research Field |
Biomedical engineering/Biological material science
|
|---|
| Research Institution | Osaka University |
|---|
Principal Investigator |
Yoshioka Yasuo 大阪大学, 微生物病研究所, 特任准教授(常勤) (00392308)
|
|---|
| Project Period (FY) |
2012-04-01 – 2016-03-31
|
| Keywords | ナノ粒子 / フラーレン |
|---|
| Outline of Final Research Achievements |
Fullerene C60 derivatives are the most promising nanomaterials because of its unique ability to scavenge large numbers of free radicals. Therefore fullerene C60 derivatives with antioxidant effects have been expected to apply to the medicine for inflammatory disease. Here I showed that Fullerene C60 derivatives might be useful preventive therapeutics for metabolic syndrome.
|
| Free Research Field |
ナノ医薬
|
